/Companies

Metallobio

Sheffield, GB · Founded 2021 · 2 known investors

Find your way into Metallobio

Sign up to see every warm intro you have to Metallobio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Metallobio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections. Its lead KLS-1 series targets complicated infections while its KLS-2 series is tuned for antimicrobial coatings on medical equipment such as catheters and joint implants.

Founders & leadership

Metallobio was founded in 2021 by Kirsty Louise Smitten and Professor Jim Thomas.

KLKirsty Louise Smitten
Kirsty Louise SmittenCo-founder and first CEO
PJ
Professor Jim ThomasChief Scientific Advisor & Co-Founder
DMDr Michael Murray
Dr Michael MurrayCEOHe has been principal at Murray International Partners since 2015, where he also works as a registered technology transfer professional and previously served as course director for China. He is an Entrepreneur in Residence at the University of Sheffield, a member of the Royal Society Industry College following a Royal Society Entrepreneur in Residence appointment, and sits on the international advisory board of the International Technology Transfer Network.

Investors · 2

Companies House · registry record

View on Companies House ↗
Registered name
METALLOBIO LIMITED
Company number
13295116
Status
Active
Company type
Private limited company
Incorporated
26 Mar 2021
Registered office
The Innovation Centre, 217 Portobello, Sheffield, South Yorkshire, S1 4DP
Nature of business (SIC)
72110 — Research and experimental development on biotechnology72190 — Other research and experimental development on natural sciences and engineering
Accounts
last made up to 31 Mar 2026 · next due 31 Dec 2027
Confirmation statement
last made up to 25 Mar 2026 · next due 8 Apr 2027

Current officers · 6

  • Ross Alexander Mcmaster — secretary, appointed 26 Mar 2021
  • Edward Littler — director, appointed 14 Mar 2025
  • Ross Alexander Mcmaster — director, appointed 26 Mar 2021
  • Michael Stephen Murray — director, appointed 24 May 2021
  • Richard Anthony Senior — director, appointed 24 May 2021
  • James Antony Thomas — director, appointed 24 May 2021

Source: Companies House public register · retrieved 20 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Metallobio do?
MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections. Its lead KLS-1 series targets complicated infections while its KLS-2 series is tuned for antimicrobial coatings on medical equipment such as catheters and joint implants.
Who founded Metallobio?
Metallobio was founded by Kirsty Louise Smitten, Professor Jim Thomas in 2021.
Who are Metallobio's investors?
Metallobio's investors include Oxford Technology Management, Seedrs.
Where is Metallobio headquartered?
Metallobio is headquartered in Sheffield, GB.